Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Rigel Pharmaceuticals
Swot
Rigel Pharmaceuticals SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Rigel Pharmaceuticals has 16 Strengths, 7 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(7)
Opportunity
(5)
Threats
(0)
Others
(1)
Consistent Highest Return Stocks over Five Years
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Big Gainers in Share Price with Good Net Profit Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 10 Years
Good quarterly growth in the recent results
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low
Promoter decreasing their shareholding
Stocks with Quarter Change % less than Industry
PE higher than Industry PE
Companies with High Debt
Top Losers
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
